The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Crucell

It’s Raining M&A: Update

Canadian developments first:

The committee is comprised of William Anderson, Robert Luba, James MacDonald and Gregory Spivy, each of whom is independent of management. James MacDonald will act as Chair of the committee. Goldman, Sachs & Co and RBC Capital Markets are assisting the Company and the Board of Directors as financial advisors.

More news on Pfizer-Wyeth, NitroMed, Sanofi, Crucell and Amylin after the jump…

Follow

Get every new post delivered to your Inbox.

Join 126 other followers